ABCL AbCellera Biologics
- 3.920
- +0.070+1.82%
AbCellera Biologics News
AbCellera Biologics | ARS: Annual Report to Security Holders
AbCellera Biologics | DEFA14A: Others
AbCellera Biologics | DEF 14A: Definitive information statements
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Carl L. G.
AbCellera Biologics | 8-K: Current report
AbCellera Biologics | 10-K: Annual report
AbCellera Biologics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AbCellera Biologics | 8-K: Current report
AbCellera Biologics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Baker Bros. Advisors LP(7.9%),Baker Bros. Advisors (GP) LLC(7.9%), etc.
AbCellera Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Carl L.G. Hansen(20.6%),Thermopylae Holdings Ltd.(19.2%)
AbCellera Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(8.29%)
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Lecault Veronique
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Stimart Tryn
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Booth Andrew
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Carl L. G.
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-10% Owner Thermopylae Holdings Ltd.
AbCellera Biologics | 8-K: Current report
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Hansen Carl L. G.
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Montalbano John S.
AbCellera Biologics | 10-Q: Q3 2023 Earnings Report
Analysis
Price Target
No Data
